Literature DB >> 21163630

High prevalence of plasmid-mediated quinolone resistance determinant aac(6')-Ib-cr amongst Salmonella enterica serotype Typhimurium isolates from hospitalised paediatric patients with diarrhoea in China.

Fangyou Yu1, Qiang Chen, Xiaojun Yu, Jingye Pan, Qiaoqiao Li, Lehe Yang, Cong Chen, Chao Zhuo, Xiaoqiang Li, Xueqing Zhang, Jinwei Huang, Liangxing Wang.   

Abstract

In this study, the antimicrobial susceptibilities and prevalence of plasmid-mediated quinolone resistance determinants amongst Salmonella enterica serotype Typhimurium isolates from hospitalised paediatric patients with diarrhoea in China were investigated. In total, 40 (64.5%) of 62 S. Typhimurium isolates were resistant to ciprofloxacin (minimum inhibitory concentration ≥0.5 μg/mL), comprising 28 isolates with low-level resistance and 12 isolates with high-level resistance. All ciprofloxacin-resistant isolates were multiresistant to other antimicrobial agents. Four pulsed-field gel electrophoresis (PFGE) clusters were found amongst the 40 ciprofloxacin-resistant isolates, amongst which PFGE clusters A, B, E and D accounted for 7, 4, 1 and 28 isolates, respectively. Two isolates with high-level ciprofloxacin resistance had two mutations in the quinolone resistance-determining regions (QRDRs) of gyrA and parC. The remaining ciprofloxacin-resistant isolates had only one mutation in the QRDR of gyrA. All 62 S. Typhimurium isolates were negative for qnr genes and qepA and 23 (37.1%) of the isolates were positive for aac(6')-Ib-cr. Nineteen isolates harbouring aac(6')-Ib-cr belonged to PFGE cluster D. A high prevalence of ciprofloxacin resistance and aac(6')-Ib-cr was found amongst S. Typhimurium isolates in China from hospitalised paediatric patients with diarrhoea not receiving quinolones. A single mutation in the QRDR of gyrA as well as production of AAC(6')-Ib-cr contributed to ciprofloxacin resistance. Clonal spread was responsible for the dissemination of aac(6')-Ib-cr amongst S. Typhimurium isolates.
Copyright © 2010 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21163630     DOI: 10.1016/j.ijantimicag.2010.10.021

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  6 in total

1.  Fluoroquinolone Resistance in Salmonella and the Utility of Pefloxacin Disk Diffusion [corrected].

Authors:  Ferric C Fang
Journal:  J Clin Microbiol       Date:  2015-08-26       Impact factor: 5.948

2.  Using In Vitro Dynamic Models To Evaluate Fluoroquinolone Activity against Emergence of Resistant Salmonella enterica Serovar Typhimurium.

Authors:  Seung-Jin Lee; Elias Gebru Awji; Na-Hye Park; Seung-Chun Park
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

3.  Performance of Etest and disk diffusion for detection of ciprofloxacin and levofloxacin resistance in Salmonella enterica.

Authors:  Eszter Deak; Janet A Hindler; Robert Skov; Maria Sjölund-Karlsson; Anita Sokovic; Romney M Humphries
Journal:  J Clin Microbiol       Date:  2014-10-29       Impact factor: 5.948

4.  Study of aminoglycoside resistance genes in enterococcus and salmonella strains isolated from ilam and milad hospitals, iran.

Authors:  Nasser Samadi; Iraj Pakzad; Alireza Monadi Sefidan; Hasan Hosainzadegan; Asghar Tanomand
Journal:  Jundishapur J Microbiol       Date:  2015-04-18       Impact factor: 0.747

5.  Emergence and Evolution of High-Level Cephalosporin-Resistant Salmonella Goldcoast in Northern Taiwan.

Authors:  Ye Feng; Yi-Jung Chang; Szu-Hsuan Fang; Lin-Hui Su; Hsin-Chieh Li; Hsin-Ping Yang; Min-Jia Yu; Cheng-Hsun Chiu
Journal:  Open Forum Infect Dis       Date:  2019-12-17       Impact factor: 3.835

6.  Incidence, clinical presentation, and antimicrobial resistance trends in Salmonella and Shigella infections from children in Yucatan, Mexico.

Authors:  Mussaret B Zaidi; Teresa Estrada-García; Freddy D Campos; Rodolfo Chim; Francisco Arjona; Magda Leon; Alba Michell; Damien Chaussabel
Journal:  Front Microbiol       Date:  2013-10-01       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.